Literatur Katheterinfektionen

1.     Prävention von Infektionen, die von Gefäßkathetern ausgehen Teil 1 – Nichtgetunnelte zentralvenöse Katheter Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch-Institut. Bundesgesundheitsbl 2017 · 60:171–206 DOI 10.1007/s00103-016-2487-4 Online publiziert: 16. Januar 2017 © Springer-Verlag Berlin Heidelberg 2017

2.     Rotstein C, Brock L, Roberts RS.The incidence of first Hickman catheterrelated infection and predictors of catheter removal in cancer patients. „Infection control and hospital epidemiology: the official journal of the Society of Hospital Epidemiologists of America.“Infect Control Hosp Epidemiol.; 16(8):451-8), 1995

3.     Simon A. et al, Healthcare associated infections in pediatric cancer patients: results of a prospective surveillance study from university hospitals in Germany and Switzerland, BMC Infectious disease, 8:70-79), 2008.

4.     Buttha A. et al. Reduction of bloodstream infections associated with catheters in pediatric intensive care unit: a stepwise approach, BMJ 334(7589) 362-5, 2007

5.     Stover et al, Nosocomial infection rates in US childrens hospitals neonatal and pediatric ICUs, AJIC 29: 152-157, 2001

6.     Saiman L. Strategies for prevention of nosocomial sepsis in the neonatal intensive care unit. Curr. Opin. Pediatric 18, 101-106, 2006

7.     Vilela R. et al. Risk factors for central venous catheter-related infections in pediatric intensive care. Clinics, 62(5): 537-44, 2007

8.     Richards M. et al. Nosocomial infections in pediatric intensive care units in the United States, Pediatrics, 103(4), 1999

9.     Crnich, Christopher J; Kluger, Daniel M; Maki, Dennis G The Risk of Bloodstream Infection in Adults With Different Intravascular Devices: A Systematic Review of 200 Published Prospective Studies Mayo Clin Proc.;81(9):1159-1171, 2006

10.  AWMF guidelines, GMS German Medical Science;7:Doc19. DOI: 10.3205/000078, URN: urn:nbn:de:0183-0000787, 2009

11.  Jarvis W.R., Edwards J.R., Culver D.H., Hughes J.M., Horan T., Emori T.G., Banerjee S., Tolson J., Henderson T., Gaynes R.P., et al.:„Nosocomial infection rates in adult and pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System.“ Am. J. Med. 91 (3B), 185-191, 1991

12.  Trautmann, Matthias; Krier, Claude: 2004; Katheterinfektionen – Prävention, Diagnose und Management von Infektionen durch intravasale Katheter, DOI: 10.1055/b-002-21515

13.  Cosgrove SE (2006) The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 42(Suppl 2):S82–S89

14.  Nowak JE, Brilli RJ, Lake MR et al (2010) Reducing catheter-associated bloodstream infections in the pediatric intensive care unit: Business case for quality improvement. Pediatr Crit Care Med 11(5):579–587

15.  Leistner R, Hirsemann E, Bloch A, Gastmeier P, Geffers C (2014) Costs and prolonged length of stay of central venous catheter-associated bloodstream infections (CVC BSI): a matched prospective cohort study. Infection 42(1):31–36

16.  Shannon RP, Patel B, Cummins D, Shannon AH, Ganguli G, Lu Y (2006) Economics of central lineassociated bloodstream infections. Am J Med Qual 21(6 Suppl):S7–S16

17.  O`Grady NP et al., Guidelines for the Prevention of Intravascular Catheter-Related Infections MMWR, / Vol. 51 / No. RR-10 Centers for Disease Control and Prevention, 2002

18.  Gilbert RE, Harden M. Effectiveness of impregnated central venous catheters for catheter related blood stream infection: a systematic review.“Current opinion in infectious diseases.“ Curr Opin Infect Dis. ;21(3):235-45, 2008

19.  Wang H, Huang T, Jing J, Jin J, Wang P, Yang M, Cui W, Zheng Y, Shen H. Effectiveness of different central venous catheters for catheter-related infections: a network meta-analysis. “The Journal of hospital infection.“ J Hosp Infect.; 76(1):1-11, 2010

20.  Pratt RJ, Pellowe CM, Wilson JA, Loveday HP, Harper PJ, Jones SR, McDougall C, Wilcox MH. epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect.;65 Suppl 1:S1-64, 2007

21.  AL Casey L A Mermel P Nightingale, TSJ Elliott Antimicrobial central venous catheters in adults: a systematic review and meta-analysis The Lancet Infectious Diseases, Volume 8, Issue 12, Pages 763 – 776, 2008

22.  AWMF guidelines, GMS German Medical Science;7:Doc19. DOI: 10.3205/000078, URN: urn:nbn:de:0183-0000787, 2009

23.  The Newcastle upon Tyne Hospitals NHS Foundation Trust, Guideline for managing long term IV access in MRSA positive patients, 2010 HTA – eusser S, Bitzer EM, Mieth I, Krauth C. Medizinische Wirksamkeit und Kosteneffektivität von Minocyclin/Rifampicin-beschichteten zentralvenösen Kathetern zur Prävention von Blutbahninfektionen bei Patienten in intensivmedizinischer Betreuung (2012). Im Internet: http://portal.dimdi.de/de/hta/hta_berichte/hta329_bericht_de.pdf; Stand: 22.02.2017

24.  Schierholz JM, Multistar Produktmonographie. Im Internet: https://www.vygon.de/index.php/fuseaction/download/lrn_file/99835_Produktmonographie_MultiStar_08_06_16.pdf; Stand: 22.02.2017

25.  Centers for Disease Control and Prevention. Workbook for Designing, Implementing, and Evaluating a Sharps Injury Prevention Program. 2008. Im Internet: http://www.cdc.gov/sharpssafety/pdf/sharpsworkbook_2008.pdf; Stand: 23.03.2015

26.  Loertzer H, et al, Use of catheters with the AgION antimicrobial system in kidney transplant recipients to reduce infection risk.   Transplant Proc. 2006 Apr;38(3):707-10.

27.  Khare J MD, et al, Reduction of catheter-related colonisation by the use of a silver zeolite-impregnated central vascular catheter in adult critical care. Infect. 2007 Feb;54(2):146-50

28.  Bertini G, et al, Reduction of catheter-related bloodstream infections in preterm infants by the use of catheters with the AgION antimicrobial system. Early Hum Dev. 2013 Jan;89(1):              21-5

29.  Schierholz, J.M., et al, Antimicrobial Central Venous Catheters in Oncology: Efficacy of a Rifampicin-Miconazol-releasing Catheter. Anticancer Research 2010;  30: 1353-1358

30.  Quatresooz P, Vroome, V, Borgers M, Cauwenbergh G, PierardG. Novelties in the multifaceted miconazole effects on skin disorders. Exert.Opin. Pharmacother. 9(11) 1927-34, 2008

31.  Vanden Bossche H, Engelen M, Rochette F. Antifungal agents of use in animal health– chemical, biochemical and pharmacological aspects J. vet. Pharmacol. Therap. 26, 5–29, 2003

32.  Schierholz, J.M., C. Fleck, Beuth J., Pulverer G., The antimicrobial efficacy of a new central venous catheter with a long-term broadspectrum activity, JAC, 46(1), 45-50, 2000

33.  Rump AFE, Güttler K, König DP, Yücel N, Korenkov M, Schierholz JM, Pharmacokinetics of the antimicrobial agents rifampicin and miconazole released from a loaded central venous catheter. J.Hosp. Inf. 53(2):129-35, 2003

34.  Yücel N, Lefering R, Max M, Rossaint R, Koch A, Schwarz R, Korenkov M, Beuth J, Bach A, Schierholz J, Troidl H, Pulverer G, Neugebauer E. Reduction of central venous catheter related infections using miconazole and rifampin loaded catheters. JAC 54(6):1109- 15, 2004

35.  Lorente L, Lecuona M, Ramos MJ, Jiménez A, Mora ML, Sierra A. The use of rifampicin- miconazole-impregnated catheters reduces the incidence of femoral and jugular catheter-related bacteremia. „Clinical infectious diseases: an official publication of the Infectious Diseases Society of America.“ Clin Infect Dis. 1; 47(9): 1171-5, 2008

36.  Lorente L, Lecuona M, Ramos MJ, Jiménez A, Mora ML, Sierra A. Rifampicin-miconazole- impregnated catheters save cost in jugular venous sites with tracheostomy. Eur J Clin Microbiol Infect Dis. 2011 Dec 22, FI: 2,631

37.  Der Effekt einer antiinfektösen Katheterbeschichtung von Einschwemmkathetern auf Katheterkolonisierung und Sekundärsepsis bei Frühgeborenen: A.W. Flemmer, N. DeMaio, S. Schubert, T. Wurster, M. Klemme, H. Messner, P. Innocenti, S. Herber-Jonat, A. Staffler; Monatsschrift Kinderheilkunde 2016 · [Suppl 2]: 164: S145; FV56; DOI 10.1007/s00112-016-0091-1; Springer-Verlag Berlin               Heidelberg 2016

38.  Lorente L, Lecuona M, Iribarren J, Jiménez J, García C, Galván R, Castedo J, Martínez J, Mora M, Sierra M, Efficiency of rifampicin– miconazole-impregnated catheters in the femoral venous site Critical Care, 13(Suppl 1):P312doi), 2009

39.  HTA – eusser S, Bitzer EM, Mieth I, Krauth C. Medizinische Wirksamkeit und Kosteneffektivität von Minocyclin/Rifampicin-beschichteten zentralvenösen Kathetern zur Prävention von Blutbahninfektionen bei Patienten in intensivmedizinischer Betreuung (2012). Im Internet: https://portal.dimdi.de/de/hta/hta_berichte/hta329_bericht_de.pdf; Stand: 23.02.2017

40.  Raad I, Darouiche R, Dupuis J, Abi-Said D, Gabrielli A, Hachem R, Wall M, Harris R, Jones J, Buzaid A, Robertson C, Shenaq S, Curling P, Burke T, Ericsson C: Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, doubleblind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med 127 , 267-274, 1997

41.  Darouiche RO, Raad II, Heard SO, Thornby JI, Wenker OC, Gabrielli A, Berg J, Khardori N, Hanna H, Hachem R, Harris RL, Mayhall G: A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med 340, 1-8, 1999

42.  Chatzinikolaou I, Hanna H, Graviss L, Chaiban G, Perego C, Arbuckle R, Champlin R, Darouiche R, Samonis G, Raad I: Clinical experience with minocycline and rifampin-impregnated central venous catheters in bone marrow transplantation recipients: efficacy and low risk of  developing staphylococcal resistance. Infect Control Hosp Epidemiol 24, 961-963, 2003

43.  León C, Ruiz-Santana S, Rello J, de la Torre MV, Vallés J, Alvarez-Lerma F, Sierra R, Saavedra P, Alvarez-Salgado F; Cabaña Study Group: Benefits of minocycline and rifampin- impregnated central venous catheters. A prospective, randomized, double-blind, controlled, multicenter trial. Intensive Care Med 30, 1891-1899, 2004

44.  Hanna H, Benjamin R, Chatzinikolaou I, Alakech B, Richardson D, Mansfield P, Dvorak T, Munsell MF, Darouiche R, Kantarjian H, Raad I: Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial. J Clin Oncol 22, 3163-3171, 2004

45.  Fraenkel D, Rickard C, Thomas P, Faoagali J, George N, Ware R: A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters. Crit Care Med 34, 668-675, 2006

46.  Darouiche RO, Berger DH, Khardori N, Robertson CS, Wall MJ Jr, Metzler MH, Shah S, Mansouri MD, Cerra-Stewart C, Versalovic J, Reardon MJ, Raad II: Comparison of antimicrobial impregnation with tunnelling of long-term central venous catheters: a randomized controlled trial. Ann Surg 242, 193-200, 2005

47.  Ramos ER, Reitzel R, Jiang Y, Hachem RY, Chaftari AM, Chemaly RF, Hackett B, Pravinkumar SE, Nates J, Tarrand JJ, Raad II. Clinical effectiveness and risk of emerging resistance associated with prolonged use of antibiotic-impregnated catheters: More than 0.5 million catheter days and 7 years of clinical experience. Crit Care Med.. [Epub ahead of print], 2010